Cinemark Holdings, Inc. 2024 Q2 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2024, for Cinemark Holdings, Inc. ("Holdings") and its primary operating subsidiary, Cinemark USA, Inc. ("CUSA"). The company operates in the motion picture exhibition industry with theaters in the U.S. and 13 Latin American countries. The filing reflects the ongoing recovery from the 2023 Hollywood strikes, which impacted the volume and mix of film releases in the second quarter of 2024.
Key Financial Metrics (Six Months Ended June 30, 2024)
| Metric | 2024 (YTD) | 2023 (YTD) |
|---|---|---|
| Total Revenue | $1,313.4 million | $1,553.0 million |
| Operating Income | $100.5 million | $196.9 million |
| Net Income (Holdings) | $71.9 million | $117.9 million |
| Net Income Attributable to Holdings | $70.6 million | $116.0 million |
| Diluted EPS | $0.51 | $0.82 |
| Operating Cash Flow | $162.2 million | $251.1 million |
| Capital Expenditures | $47.2 million | $54.6 million |
| Cash and Equivalents (End of Period) | $788.8 million | $758.0 million |
| Total Debt (Carrying Value) | $2,277.4 million | $2,432.1 million |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 15.4% year-over-year. U.S. attendance dropped 17.7% to 52.7 million patrons, and international attendance fell 14.5% to 37.0 million, primarily due to a lower concentration of high-grossing titles following the 2023 strikes.
- Profitability Compression: Operating income declined 49.0% to $100.5 million. Operating margins compressed from 12.7% in 2023 to 7.7% in 2024 due to the revenue decline and fixed cost structures.
- Cost Management: Despite lower revenue, the company reduced operating costs. Salaries and wages decreased 7.1% and facility lease expenses decreased 4.6% due to theater closures and lease renegotiations. However, concession supplies as a percentage of revenue increased slightly due to inflation.
- Debt Reduction: The company redeemed the remaining $150.0 million of its 8.75% Secured Notes in May 2024. Total long-term debt carrying value decreased by approximately $154.7 million compared to the prior year-end.
- Tax Benefit: The company recorded a significant income tax benefit of $28.6 million (effective rate of -66.0%) due to the release of valuation allowances in certain foreign jurisdictions, contrasting with a tax expense of $8.4 million in the prior year.
Guidance, Outlook, and Risks
- Subsequent Financing Activity: On July 18, 2024, CUSA issued $500.0 million of 7.00% Senior Notes due 2032. Concurrently, it completed a tender offer to repurchase $345.3 million of its 5.875% Senior Notes due 2026, leaving $59.7 million outstanding.
- Capital Allocation: The company plans to fund capital expenditures through cash flow from operations and existing credit facilities. There are signed commitments for $29.9 million in remaining investment for new theater development.
- Dividend Status: The quarterly dividend to shareholders remains suspended due to the impact of the COVID-19 pandemic.
- Risks: Key risks include the continued impact of the Hollywood strikes on film release schedules, foreign currency exchange fluctuations (particularly in Brazil and Argentina), inflationary pressures on labor and concession costs, and competition from streaming services.
- Legal Proceedings: The company is involved in litigation regarding a property insurance claim related to COVID-19 closures (Factory Mutual Insurance Company) and a class action lawsuit regarding draft beer cup labeling. Management believes potential liabilities are not material.
Investor Verification Checklist
- Debt Structure: Verify the impact of the new $500 million 7.00% Senior Notes issuance and the reduction of the 5.875% Senior Notes on future interest expense and leverage ratios.
- Attendance Trends: Monitor Q3 and Q4 attendance figures to assess the recovery trajectory post-strike and the effectiveness of pricing strategies (average ticket price increased 2.0% YTD).
- Foreign Currency Exposure: Review the impact of exchange rate fluctuations on international segment results, noting the significant translation losses recorded in Q2 2024.
- Valuation Allowances: Confirm the sustainability of the tax benefits derived from the release of foreign valuation allowances and the likelihood of similar releases in the U.S. within the next 12 months.
- Capital Expenditures: Track progress on the $29.9 million in committed capital expenditures for new theater openings and remodels.